Inflammation Modulator
What is Inflammation Modulator?
What is Inflammation Modulator?
This premium inflammation support supplement is your daily ally to help relieve mild joint pain and inflammation, it supports antioxidant activity and general health and wellbeing.
Melrose FutureLab Inflammation Modulator features clinically studied Meriva® Curcumin Phytosome® and Palmitoylethanolamide (PEA) in bioavailable forms. Meriva® delivers optimised absorption of curcumin, while PEA helps support mild inflammation relief and joint comfort.
Ingredients
Ingredients
Each capsule contains:
LipiSperse® HydroCurc®
equiv. to Curcumin 211 mg
equiv. to Curcuminoids 200 mg
LipiSperse® Levagen®+
containing Palmidrol (PEA) 300 mg
How to use
How to use
Adults - Take one to two capsules with water, daily, or as directed
by your health professional
Warnings
Warnings
Adults only. The medicine may interact with other prescription
analgesic medicines, please consult your healthcare practitioner before use.
Not to be used for more than 21 consecutive days. In very rare cases,
Curcuma species may harm the liver. Stop use and see a doctor if you have
yellowing skin/eyes or unusual: fatigue, nausea, appetite loss, abdominal pain,
dark urine, or itching. If symptoms persist, talk to your health professional.
Store below 250C away from direct sunlight.
Do not use if tamper evident seals are broken
or missing.
Quality You Can Trust
Quality You Can Trust
Not all supplements are created equal, so it’s important to choose those of premium quality that have been independently tested for purity and quality.
This product is listed on the Australian Register of Therapeutic Goods (ARTG) with AUST L 522166 and manufactured in accordance with the TGA’s guidelines for listed medicines, ensuring it meets stringent Australian quality and safety standards.
5 Benefits of Inflammation Modulator
Mild Inflammation Can Increase with Age
Inflammation is part of the body's normal response to everyday physical stress or minor injury. As we age, some people may experience more frequent mild joint discomfort or inflammation.
FutureLab Inflammation Modulator is formulated with HydroCurc® Curcuma longa Rhizome Extract. and Palmidrol (PEA) to help relieve mild joint inflammation and pain, and support antioxidant activity and general health and wellbeing.
✓ Vegan
✓ Dairy Free
✓ Gluten Free
✓ Proudly Australian Owned
Key Ingredients
LipiSperse® Curcuma longa Rhizome Extract
Antioxidant & Anti-Inflammatory Support.
HydroCurc® Curcuma longa Rhizome Extract is traditionally used for its antioxidant and anti-inflammatory properties. This formula provides 100mg of dry concentrate extract, equivalent to 16.5g of fresh Curcuma longa rhizome, delivered using LipiSperse® cold-water dispersion technology. In a published human trial, curcumin delivered with LipiSperse® produced significantly higher plasma curcuminoid concentrations than standard curcumin extract.^ Together, this helps support antioxidant activity and relieve mild joint inflammation and pain.
Palmitoylethanolamide (PEA)
Inflammation Support.
Palmitoylethanolamide (PEA), listed on the ARTG as palmidrol, is a naturally occurring fatty acid amide known for its role in helping relieve mild joint pain and inflammation. It works by supporting the body's endocannabinoid system and complements Curcuma longa extract to help support mild joint inflammation.
Recommended for You
Complete your routine.
Add all three to your cart in one click.
Still on the fence?
See what most people ask before trying.
Still have questions? See all FAQs or Contact Us and our team will be happy to help.
Inflammation Modulator is an anti-inflammatory supplement that combines Curcuma longa rhizome extract and Palmidrol (PEA) to help relieve mild joint pain, reduce mild joint inflammation, support antioxidant activity, and maintain general health and wellbeing.
This formula features Curcuma longa rhizome extract delivered using LipiSperse® HydroCurc® technology, shown in published research to increase curcumin's bioavailability compared to standard curcumin extract. It's combined with Palmidrol (PEA), a compound studied for its role in relieving mild joint pain and inflammation.
This supplement is suitable for adults seeking anti-inflammatory support for mild joint inflammation, mild arthritis symptoms, or general antioxidant support. If you are unsure whether this product is right for you, speak with your health professional. Not to be used for more than 21 consecutive days. In very rare cases, Curcuma species may harm the liver. Stop use and see a doctor if you have yellowing skin/eyes or unusual: fatigue, nausea, appetite loss, abdominal pain, dark urine, or itching.
Individual results may vary. For best results, take consistently as part of your daily health routine and speak with your health professional for personalised advice. Not to be used for more than 21 consecutive days. In very rare cases, Curcuma species may harm the liver. Stop use and see a doctor if you have yellowing skin/eyes or unusual: fatigue, nausea, appetite loss, abdominal pain, dark urine, or itching.
This formula contains Curcuma longa extract and Palmidrol (PEA), which may interact with prescription analgesic medicines. Speak with your healthcare practitioner before use if you are taking other medications or supplements. Not to be used for more than 21 consecutive days. In very rare cases, Curcuma species may harm the liver. Stop use and see a doctor if you have yellowing skin/eyes or unusual: fatigue, nausea, appetite loss, abdominal pain, dark urine, or itching.
Inflammation Modulator is vegan, gluten free, and dairy free. Always speak with your health professional if you are unsure whether this product is right for you.
References:
^Cuomo, J. et al. (2011). Comparative Absorption of a Standardized Curcuminoid Mixture and Its Lecithin Formulation. J Nat Prod, 74(4), 664–669.
Belcaro, G. et al. (2010). Meriva® for Osteoarthritis. Altern Med Rev, 15(4), 337–44.
Pivari, F. et al. (2022). Curcumin Supplementation (Meriva®) Modulates Inflammation and Gut Microbiota. Nutrients, 14(1):231.
Lang-Illievich, K. et al. (2023). Palmitoylethanolamide for Chronic Pain: Meta-Analysis. Nutrients, 15(6):1350.
Artukoglu, B.B. et al. (2017). Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis. Pain Physician, 20(5), 353–362.
Franceschi C, Campisi J. Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines. Front Immunol. 2018 Apr 9;9:586. doi: 10.3389/fimmu.2018.00586.